GI & Endoscopy

Here are two gastroenterologists making headlines the week of April 24, 2017.

The American Gastroenterological Association Research Foundation awarded 52 researchers funding in its 2017 award year.

A study published in The Lancet Oncology examined surveillance colonoscopy's effect on colorectal cancer risk.

Motus GI Holdings announced that Flourtown, Pa.-based Hillmont GI was the first U.S. ambulatory endoscopy center to use its Pure-Vu system.

A study published in Gastroenterology examined the direct oral anticoagulants' gastrointestinal safety.

The FDA approved Stivarga for hepatocellular carcinoma patients. It's the first new FDA-approved liver cancer treatment in nearly a decade.

James Schnell, MD, is a gastroenterologist at Charleston, S.C.-based Palmetto Digestive Health Specialists.

The International Association of HealthCare Professionals is including Todd Baron, MD, in its "The Leading Physicians of the World," publication.

The American College of Gastroenterology, Allergan and Ironwood Pharmaceuticals named Kimberly P. of Pennsylvania the "Picture My IBS" winner.

Australian scientists completed a phase one human clinical trial of an ingestible biosensor that measures gas produced by the gut and transmits results to a smartphone, MedDevice Online reports.